Double maintains 7 strategies that include TMO - Thermo Fisher Scientific, Inc.
Current Value
$428.621 Year Return
Current Value
$428.621 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DHR | 80.56% | $144.92B | -15.63% | 0.58% |
A | 79.31% | $34.28B | -4.34% | 1.00% |
MTD | 78.16% | $25.06B | -10.96% | 0.00% |
RVTY | 77.51% | $11.89B | -1.62% | 0.28% |
TECH | 74.86% | $8.34B | -25.57% | 0.60% |
IQV | 71.62% | $28.48B | -20.39% | 0.00% |
BIO | 70.72% | $6.82B | -7.19% | 0.00% |
BRKR | 69.95% | $6.43B | -31.33% | 0.47% |
WAT | 68.23% | $20.94B | +22.41% | 0.00% |
AVTR | 64.77% | $9.47B | -33.89% | 0.00% |
SWK | 62.77% | $11.07B | -10.42% | 4.59% |
QGEN | 62.39% | $10.53B | +16.53% | 0.51% |
ITW | 61.70% | $75.14B | +8.67% | 2.34% |
MAS | 61.00% | $14.19B | +3.86% | 1.79% |
TXT | 60.77% | $14.79B | -4.95% | 0.10% |
RGEN | 60.75% | $7.13B | +5.13% | 0.00% |
PFE | 60.58% | $143.95B | -8.59% | 6.72% |
NDSN | 60.11% | $12.59B | -2.13% | 1.39% |
LYB | 59.45% | $20.11B | -34.27% | 8.60% |
PPG | 58.38% | $26.92B | -5.03% | 2.30% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CPSH | -0.14% | $42.27M | +74.25% | 0.00% |
IRWD | -0.18% | $119.70M | -87.89% | 0.00% |
DFDV | -0.25% | $300.56M | +2,130.16% | 0.00% |
STG | -0.37% | $30.78M | -22.51% | 0.00% |
ALHC | 0.70% | $2.69B | +71.20% | 0.00% |
CME | -0.76% | $99.39B | +40.68% | 3.86% |
UUU | -0.81% | $7.17M | +101.30% | 0.00% |
PULM | -0.89% | $25.57M | +219.63% | 0.00% |
PHYS.U | 0.91% | - | - | 0.00% |
GFI | 0.98% | $21.56B | +57.55% | 2.31% |
OR | 1.00% | $4.80B | +61.45% | 0.75% |
K | -1.14% | $27.76B | +41.17% | 2.85% |
RLMD | 1.33% | $19.95M | -80.03% | 0.00% |
LRN | 1.55% | $5.99B | +100.06% | 0.00% |
GORV | -1.57% | $27.07M | -91.17% | 0.00% |
CYCN | -1.59% | $10.59M | +46.35% | 0.00% |
HRTG | 1.78% | $702.31M | +250.23% | 0.00% |
AIFU | -1.86% | $6.79B | +102.19% | 0.00% |
MVO | -1.93% | $66.47M | -37.17% | 21.45% |
CARV | -1.95% | $8.88M | +26.23% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -47.64% | $99.63M | 0.59% |
VIXY | -44.92% | $164.54M | 0.85% |
IVOL | -31.30% | $347.03M | 1.02% |
BTAL | -27.72% | $296.22M | 1.43% |
CLIP | -26.47% | $1.51B | 0.07% |
FTSD | -22.50% | $231.81M | 0.25% |
TPMN | -20.85% | $30.70M | 0.65% |
XONE | -16.75% | $625.28M | 0.03% |
SHYM | -16.44% | $357.13M | 0.35% |
FXY | -14.40% | $816.38M | 0.4% |
STPZ | -14.38% | $450.47M | 0.2% |
SPTS | -13.79% | $5.80B | 0.03% |
TFLO | -11.19% | $6.82B | 0.15% |
XHLF | -11.01% | $1.73B | 0.03% |
KCCA | -10.93% | $109.43M | 0.87% |
STOT | -10.83% | $254.07M | 0.45% |
UTWO | -10.41% | $379.52M | 0.15% |
GBIL | -10.17% | $6.37B | 0.12% |
ULST | -9.99% | $654.75M | 0.2% |
SCHO | -9.92% | $11.03B | 0.03% |
Yahoo
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc. (NYSE:TMO) partnered with Xcell Biosciences, an instrumentation firm specializing in cell and gene therapy applications, to advance research on tumor-infiltrating lymphocytes (TILs) and regulatory T cells (Tregs). While an extensive amount of progress has been […]
SeekingAlpha
TMO's financials show profitability but lack a clear positive trend, creating ongoing pressure on the stock price and limiting near-term upside. Click to read.
Yahoo
Demand for validated consumables and innovative testing methods like PCR and chromatography persists, driven by regulatory needs and environmental considerations Biopharmaceuticals Manufacturing Consumables Testing Market Biopharmaceuticals Manufacturing Consumables Testing Market Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type, Testing Type, Technology, Application, End User - Global Forecast to 2030" has been added to R
Yahoo
Thermo Fisher Scientific is poised to release its second-quarter results later this month, and analysts project a single-digit earnings drop.
SeekingAlpha
Thermo Fisher's strong economic moat, slowing growth, and fair valuation. Valuation is reasonable, trading near decade-low multiples. See more on TMO stock here.
MarketWatch
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPH | 75.63% | $729.81M | 0.4% |
IYH | 73.33% | $2.73B | 0.39% |
VHT | 73.22% | $15.35B | 0.09% |
FHLC | 73.02% | $2.44B | 0.084% |
MOAT | 73.01% | $12.66B | 0.47% |
XLV | 71.66% | $34.28B | 0.09% |
BBH | 71.52% | $330.62M | 0.35% |
FXH | 71.38% | $903.07M | 0.62% |
FBT | 70.83% | $1.01B | 0.54% |
IXJ | 70.15% | $3.75B | 0.41% |
IBB | 69.74% | $5.26B | 0.45% |
DSTL | 67.01% | $1.79B | 0.39% |
NOBL | 66.95% | $11.37B | 0.35% |
KNG | 66.23% | $3.76B | 0.75% |
DGRO | 65.82% | $31.98B | 0.08% |
PBE | 65.50% | $223.19M | 0.58% |
SMOT | 65.22% | $387.12M | 0.49% |
FIW | 64.98% | $1.86B | 0.51% |
RSP | 64.84% | $72.80B | 0.2% |
FLQM | 64.64% | $1.67B | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TYA | -0.19% | $152.69M | 0.15% |
IBND | -0.23% | $384.31M | 0.5% |
STXT | 0.25% | $129.40M | 0.49% |
IBMN | 0.31% | $447.08M | 0.18% |
FLMI | -0.35% | $725.99M | 0.3% |
IBTM | 0.42% | $316.49M | 0.07% |
SMMU | -0.42% | $892.02M | 0.35% |
BILZ | 0.51% | $821.74M | 0.14% |
BNDX | -0.57% | $67.52B | 0.07% |
SCHR | -0.58% | $10.92B | 0.03% |
SHY | 0.78% | $23.83B | 0.15% |
CMBS | 0.83% | $449.66M | 0.25% |
JPLD | 0.84% | $1.77B | 0.24% |
BOXX | 0.98% | $6.80B | 0.19% |
SPTI | -1.03% | $8.82B | 0.03% |
FXC | -1.05% | $93.16M | 0.4% |
LDUR | -1.09% | $929.65M | 0.5% |
IBTL | -1.16% | $381.01M | 0.07% |
USFR | -1.25% | $18.56B | 0.15% |
SHV | 1.28% | $20.64B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -9.72% | $19.66M | -19.53% | 0.00% |
VSTA | -7.58% | $344.07M | +39.29% | 0.00% |
VSA | -7.50% | $8.67M | -19.04% | 0.00% |
MSIF | -5.35% | $769.47M | +36.17% | 7.61% |
CBOE | -5.32% | $24.23B | +35.36% | 1.09% |
NGVC | -4.37% | $909.29M | +82.08% | 1.16% |
CNK | -4.25% | $3.47B | +41.29% | 0.53% |
VHC | -3.08% | $48.19M | +108.24% | 0.00% |
MKTX | -3.00% | $8.22B | +9.03% | 1.38% |
KR | -2.93% | $46.43B | +38.38% | 1.85% |
LITB | -2.72% | $21.24M | -78.57% | 0.00% |
GALT | -2.23% | $137.34M | +0.93% | 0.00% |
QNTM | -2.10% | $51.94M | +107.44% | 0.00% |
CARV | -1.95% | $8.88M | +26.23% | 0.00% |
MVO | -1.93% | $66.47M | -37.17% | 21.45% |
AIFU | -1.86% | $6.79B | +102.19% | 0.00% |
CYCN | -1.59% | $10.59M | +46.35% | 0.00% |
GORV | -1.57% | $27.07M | -91.17% | 0.00% |
K | -1.14% | $27.76B | +41.17% | 2.85% |
PULM | -0.89% | $25.57M | +219.63% | 0.00% |